GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports

The logo of GE Healthcare is seen on their plant in the IDA (Industrial Development Agency) estate, in Carrigtwohill, County Cork, Ireland March 28, 2025.

The logo of GE Healthcare is seen on their plant in the IDA (Industrial Development Agency) estate, in Carrigtwohill, County Cork, Ireland March 28, 2025. (REUTERS/Clodagh Kilcoyne)


1 photo
Save Story

Estimated read time: Less than a minute

Sept 13 — GE HealthCare Technologies is in ​talks over a possible $1 billion deal to buy radiopharmaceutical developer Sofie ‌Biosciences, the Financial Times reported on Sunday, citing ⁠people familiar ​with the matter.

Here ⁠are some details:

• A deal ‌for Sofie, ‌which specializes in radioactive chemicals used in ⁠cancer scans, ⁠could be announced as soon as next week, the report said.

• Reuters could not immediately verify the report. GE HealthCare declined to ‌comment while Sofie ​Biosciences could not be immediately reached for comment outside regular business hours.

• The potential deal would be GE HealthCare's second major acquisition since it broke away as part ​of U.S. conglomerate General Electric's ‌three-way split ‌in ⁠2024.

• Acquiring Sofie would help bolster GE HealthCare's pharmaceutical diagnostics division, which supplies the agents and chemicals used ‌in scans, the ​report said.

(Reporting by ‌Devika Nair ⁠in ​Bengaluru; Editing by Susan Fenton and David ​Gregorio)

Photos

Most recent Lifestyle stories

Related topics

Reuters

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Notice.
    Newsletter Signup

    KSL Weather Forecast

    KSL Weather Forecast
    Play button